Analogous Art Must Be Compared to the Challenged Patent | Knobbe Martens
In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the Federal Circuit reversed an obviousness determination by the PTAB. At issue was Sanofi’s reissued U.S....
Source: jdsupra.com